Selecta Biosciences

Selecta Biosciences

Biotechnology Research Watertown, Ma, United States 12 employees SELB
Employees
12

Selecta Biosciences Overview

Headquarters
Watertown, Ma, United States
Phone Number
Available in AeroLeads
Website
selectabio.com
Industry
Biotechnology Research
Employees
12
Stock Symbol
SELB
Funding
60.3M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Selecta Biosciences

In November 2023, Selecta Biosciences Inc. (NASDAQ: SELB) merged with Cartesian Therapeutics to create a publicly traded company pioneering RNA cell therapy to treat autoimmune disease. The combined company will focus on advancing Cartesian’s wholly owned pipeline, including Descartes-08, Cartesian’s clinical-stage lead product candidate being evaluated in patients with myasthenia gravis and other autoimmune diseases. For more information about the company and updates, please visit https://www.cartesiantherapeutics.com/ or follow us on LinkedIn @Cartesian-Therapeutics.

Selecta Biosciences Contact Details

People in AeroLeads
2

Selecta Biosciences Org Chart

Sample employees and titles
Name Title Contact
Emanuela Suraci Stilista Presso Selecta Biosciences
View
Natalia Drefs Senior Research Assistant
View

Employees by Management Level

Individual contributor 3 profiles
Manager 1 profile
Senior / Lead 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 1 1 0

Compare Similar Companies to Selecta Biosciences